Fred Hutch’s collaborative culture allows our researchers to generate discoveries as quickly as possible and translate them into new treatments, diagnostic tools and preventive strategies. Our integrated research centers, institutes, networks and other cross-divisional programs are crucial to maintaining that culture.
ON THIS PAGE
Integrated Research Centers | Institutes | Networks | Interdiscipinary Programs | SPOREs
Immunotherapy IRC
Fred Hutch is at the forefront of a fundamental shift in the way cancer is treated and cured. Our Immunotherapy Integrated Research Center (Immunotherapy IRC) researchers are developing new ways to empower the immune system to fight cancer and other diseases, with potentially fewer side effects than with conventional treatments.
Pathogen-Associated Malignancies IRC
Each year, 14 million people worldwide are diagnosed with cancer, and up to 20 percent of those cancers are caused, directly or indirectly, by viruses and other pathogens. Pathogen-Associated Malignancies Integrated Research Center's (PAM IRC) goal is to lead the way in eliminating that burden by spurring advances in the understanding, prevention and treatment of pathogen-associated cancers.
Translational Data Science IRC
Translational Data Science Integrated Research Center (TDS IRC) researchers are building on recent data-driven advances in the biomedical sciences to open up new avenues for preventing and treating cancer and related diseases. Our data scientists develop statistical methods and computational tools for managing massive data sets and work closely with our researchers and clinicians to translate data-driven discoveries into improved patient care.
Hutchinson Institute for Cancer Outcomes Research
Hutchinson Institute for Cancer Outcomes Research (HICOR) is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer — and ultimately lead to better outcomes for patients.
Institute for Prostate Cancer Research
The Institute for Prostate Cancer Research (IPCR) is a collaborative effort between Fred Hutch and UW Medicine. Together, we are a team of more than 40 scientists and scientist-clinicians in multiple disciplines.
Stuart and Molly Sloan Precision Oncology Institute
The Sloan Precision Oncology Institute research includes genetics and genomics, metabolomics, tumor microenvironment, environmental exposures and theranostics focused on risk, prevention, diagnosis and treatment using data developed in partnership with patients.
Cancer Screening Research Network
The Cancer Screening Research Network's (CSRN) primary focus is to reduce cancer-related illnesses and deaths by evaluating new and complex technologies that screen for cancer. The CSRN is a multi-center effort, funded by the National Cancer Institute. Fred Hutch Cancer Center serves as the coordinating and communications center as well as the statistics and data management center.
HIV Vaccine Trials Network
Fred Hutch leads the HIV Vaccine Trials Network (HVTN), a critical global effort aimed at creating an effective vaccine against HIV. HVTN operates over 30 sites on five continents and has collaborations with researchers at numerous internationally renowned research institutes.
International Histocompatibility Working Group
The International Histocompatibility Working Group (IHWG) provides a comprehensive inventory of human leukocyte antigen (HLA) reference genes to support worldwide research in immunogenetics —offering selected cell lines and DNA from its substantial bank, which includes more than 1,000 cell lines from selected families and individuals with varied ethnic and immunologic backgrounds.
Specimen and Data Access Network
Specimen and Data Access Network (SAN) is a network of Pacific Northwest research institutions focused on supporting and accelerating innovations in patient care. Together, we are working to facilitate access to specimens for our research communities for the development of new methods of preventions, diagnostics and treatments.
Center for Metastasis Research eXcellence
Fred Hutch has a growing cross-divisional Global Oncology program that investigates globally relevant cancers and seeks to understand the varied genetics and biology of common cancers around the world. Through our Global Oncology program, we aim to develop high-impact, low-cost diagnostic tools and therapies that can be used in low-resource settings worldwide.
Fred Hutch Innovation Lab
The Fred Hutch Innovation Lab is spurring novel technology development and adoption. Scientists are leading the in-house development and early adoption of powerful new research technologies that hold the potential to drive lifesaving discoveries in cancer immunology and other areas of science.
Global Oncology
Fred Hutch has a growing cross-divisional Global Oncology program that investigates globally relevant cancers and seeks to understand the varied genetics and biology of common cancers around the world. Through our Global Oncology program, we aim to develop high-impact, low-cost diagnostic tools and therapies that can be used in low-resource settings worldwide.
Office of Community Outreach & Engagement
The Office of Community Outreach & Engagement (OCOE) promotes health equity by generating and facilitating cancer research that addresses and reduces cancer health disparities in the catchment area through authentic engagement, a community-engaged/community-based participatory research approach and education driven by community need.
Population Health Colorectal Cancer Screening Program
The Population Health Colorectal Cancer Screening Program is a collaborative effort between Fred Hutch and UW Medicine. The program's goals are to eradicate colorectal cancer by improving screening, reducing racial, ethnic, and socioeconomic disparities, and improving follow-up for those with abnormal non-invasive screening tests.
Office of Translational Research
The Office of Translational Research (OTR) is committed to accelerating translational research through building bridges across disciplines to facilitate science and improve lives. With creativity, collaboration and inclusivity, we connect diverse minds and break down barriers bringing us closer to a cancer-free world.
Lung SPORE
The Lung Specialized Project of Research Excellence (SPORE) brings together experts from across Fred Hutch and its partner organizations to fast-track the latest breakthroughs in its labs to patients and those at risk of developing lung cancer. The Lung SPORE has leveraged the strengths of its investigators and Fred Hutch to tackle critical barriers precluding meaningful improvements in lung cancer survival rates
PNW Prostate Cancer SPORE
The Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE), one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort between Fred Hutch, University of Washington and its affiliated institutions, the University of British Columbia and the Prostate Centre of Vancouver General Hospital, and Oregon Health and Sciences University, working together toward a common goal of reducing morbidity and mortality associated with prostate cancer.
Faculty & Labs
Our world-class scientists have revolutionized prevention, detection and treatment of many cancers and other diseases.
Scientific Divisions
Researchers in our scientific divisions are generating pathbreaking discoveries and translating them into interventions that save lives.